Image

A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Study of Investigational Medication in Advanced or Metastatic Solid Tumors

Recruiting
18 years and older
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

The purpose of this study is to investigate advanced or metastatic solid tumors. This study evaluates an investigational medication.

This study focuses on assessing the safety, tolerability, and therapeutic activity of the investigational medication. It also examines the pharmacokinetics, which is how the drug moves through the body, and pharmacodynamics, which is how the drug affects the body.

  • Who can participate: Adults aged 18 years and older with advanced or metastatic solid tumors can participate. Key eligibility includes adequate organ function and measurable disease. Participants must have resolved side effects from prior treatments to a certain level.
  • Study details: Participants will receive the investigational medication to evaluate its effects. The study does not use a placebo.
Print
Study details
    Advanced Solid Tumor
    Metastatic Solid Tumor
    Non-small Cell Lung Cancer (NSCLC)
    Head and Neck (HNSCC)
    Pancreatic Cancer
    Renal Cell Carcinoma (RCC)

NCT07172802

GI Innovation, Inc.

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.